Skip to content

Author

R. Colombatti

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Clinical trial Open access Oct 2026

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

BACKGROUND Persistent haemolytic anaemia and recurrent vaso-occlusion drive complications and accelerate mortality in sickle cell disease. Mitapivat, an oral allosteric activator of pyruvate kinase, increases ATP and decreases 2,3-DPG with the potential to improve haemolytic anaemia and reduce sickling. We aimed to eva...

B. Andemariam, K. Kuo, F. Algahtani et al. · 1 citation
Review Open access Oct 2026

Artificial intelligence knowledge, use, and perceived barriers among health care professionals in rare hematological disease networks

AI techniques are increasingly demonstrating potential in improving patient outcomes, with applications rapidly developing in rare hematological diseases (RHDs), including hemoglobinopathies. To guide AI introduction, it is essential to explore healthcare professionals’ (HCPs) knowledge of basic AI concepts, atti...

E. Mezzalira, M. D'Agnolo, M. Boaro et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.